Copyright
©The Author(s) 2015.
World J Gastroenterol. May 28, 2015; 21(20): 6236-6245
Published online May 28, 2015. doi: 10.3748/wjg.v21.i20.6236
Published online May 28, 2015. doi: 10.3748/wjg.v21.i20.6236
Table 2 Viral kinetics and SVR
| Percentage | Percentage who went on to achieve SVR | P value | |
| RVR | 0.0003 | ||
| Yes | 14 | 31 | |
| No | 86 | 69 | |
| Week 8 negativity | < 0.0001 | ||
| Yes | 29 | 72 | |
| No | 71 | 20 | |
| EVR | < 0.0001 | ||
| Yes | 41 | 72 | |
| No | 59 | 11 |
- Citation: Lim KB, Sima HR, Fiel MI, Khaitova V, Doucette JT, Chernyiak M, Ahmad J, Bach N, Chang C, Grewal P, Kim-Schluger L, Liu L, Odin J, Perumalswami P, Florman SS, Schiano TD. Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus. World J Gastroenterol 2015; 21(20): 6236-6245
- URL: https://www.wjgnet.com/1007-9327/full/v21/i20/6236.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i20.6236